Business Standard

SoftBank touts Vision Fund gains, ditches operating profit as yardstick

Chief Executive Masayoshi Son has long emphasised the total value of assets as his preferred yardstick

SoftBank
Premium

Its stakes in nine public companies, including the recently listed Relay Therapeutics Inc, are worth $14.6 billion, compared with their $9.9 billion acquisition cost.

Sam Nussey | Reuters Tokyo
SoftBank Group Corp broke with tradition on Tuesday and declined to disclose operating profit in its quarterly results, saying the measure was "not useful" to gauge performance, and instead pointed to a $2.8 billion gain at its Vision Fund.

Chief Executive Masayoshi Son has long emphasised the total value of assets as his preferred yardstick. By jettisoning operating profit, however, SoftBank could further stoke investor complaints about a firm long seen as opaque and hard to value.

SoftBank, which plunged to a record operating loss last year following writedowns at the Vision Fund, trumpeted a 297 billion yen ($2.80 billion)

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in